SEER Cancer Incidence Data with Population and Registry Details

SEER Limited-Use cancer incidence data from the National Cancer Institute's SEER Program includes patient demographics, primary tumor site, morphology, stage at diagnosis, treatment, and vital status follow-up. It is the only comprehensive U.S. population-based source with stage-specific survival rates. Geographic coverage is at the county and SEER registry level.

Use Cases

• Analyze cancer stage at diagnosis distribution across patient demographics to identify disparities.
• Model survival rates based on primary tumor site, morphology, and first course of treatment.
• Study geographic variations in cancer incidence using county and SEER registry identifiers.

Strengths

• Data originates from the National Cancer Institute's SEER Program, a high-quality, population-based collection.
• Includes detailed clinical variables such as stage at diagnosis and first course of treatment.
• Provides geographic granularity at both county and SEER registry levels.

Limitations

• Specific row count, column count, and temporal coverage are not provided in the input.
• Data access is 'Limited-Use', which may involve specific licensing or usage restrictions.
• File format is listed as HTML, which is atypical for structured tabular data analysis.

Provenance

Source

National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program

Collection Method

Collected from population-based cancer registries across the United States.

Time Range

null

Freshness

null

Geography

United States, with data available at county and SEER registry levels.